# Novartis (NVS) cash on hand: $11.53B in 2025

URL: https://funkfolio.com/stock/NVS/cash

> Novartis (NVS) cash on hand was $11.53B at the end of fiscal 2025, down 13.6% from fiscal 2024. Year-by-year chart and table.

---

## Novartis (NVS) cash on hand

**Cash · fiscal 2025:** $11.53B at Dec 31, 2025

Novartis (NVS) held cash of $11.53B at the end of fiscal 2025 (December 31, 2025). That is 13.6% lower than the $13.35B of fiscal 2024. Figures as of 18 Nov 2026, 09:52 UTC, from Yahoo Finance.

### Key facts

- **Cash, fiscal 2025:** $11.53B
- **Change on fiscal 2024:** −13.6%
- **Highest on record:** $18.62B fiscal 2022
- **Lowest on record:** $11.53B fiscal 2025
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 09:52 UTC. Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Novartis cash on hand, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $18.62B in fiscal 2022 and the lowest $11.53B in fiscal 2025.

### Cash by fiscal year

### Novartis cash on hand, year by year

Novartis (NVS) cash on hand by fiscal year

| Fiscal year | Cash | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $11.53B | 13.6% down | Dec 31, 2025 |
| 2024 | $13.35B | 4.4% down | Dec 31, 2024 |
| 2023 | $13.96B | 25.0% down | Dec 31, 2023 |
| 2022 | $18.62B | — | Dec 31, 2022 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.

### How to read it

Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.

### Novartis, figure by figure

- [Novartis market cap](https://funkfolio.com/stock/NVS/market-cap)
- [Novartis revenue](https://funkfolio.com/stock/NVS/revenue)
- [Novartis earnings](https://funkfolio.com/stock/NVS/earnings)
- [Novartis earnings per share (EPS)](https://funkfolio.com/stock/NVS/eps)
- [Novartis P/E ratio](https://funkfolio.com/stock/NVS/pe-ratio)
- [Novartis P/S ratio](https://funkfolio.com/stock/NVS/ps-ratio)
- [Novartis P/B ratio](https://funkfolio.com/stock/NVS/pb-ratio)
- [Novartis free cash flow](https://funkfolio.com/stock/NVS/free-cash-flow)
- [Novartis operating margin](https://funkfolio.com/stock/NVS/operating-margin)
- [Novartis dividend](https://funkfolio.com/stock/NVS/dividend)
- [Novartis shares outstanding](https://funkfolio.com/stock/NVS/shares-outstanding)
- [Novartis total debt](https://funkfolio.com/stock/NVS/total-debt)
- [Novartis total assets](https://funkfolio.com/stock/NVS/total-assets)
- [Novartis return on equity (ROE)](https://funkfolio.com/stock/NVS/roe)
- [Novartis return on invested capital (ROIC)](https://funkfolio.com/stock/NVS/roic)

[Novartis (NVS) overview: price, valuation and scorecard](https://funkfolio.com/stock/NVS) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Novartis cash on hand: questions and answers

**How much cash does Novartis have?**

Novartis (NVS) held cash of $11.53B at the end of fiscal 2025 (December 31, 2025). That is 13.6% lower than the $13.35B of fiscal 2024.

**What are the highest and lowest cash figures on record for Novartis?**

Across the 4 fiscal years on record (2022–2025), the highest was $18.62B in fiscal 2022 and the lowest $11.53B in fiscal 2025.

**How is Novartis's cash calculated?**

Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone. For Novartis it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: cash on hand

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Novartis (NVS) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/cash

Underlying data: Yahoo Finance.
